Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Next Generation Sequencing Kits Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
5.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
5.2.3. By Usage Area (Clinical, Research)
5.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
5.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
5.2.6. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.7. By Company (2022)
5.3. Market Map
5.3.1 By Workflow
5.3.2 By Sequencing Type
5.3.3 By Usage Area
5.3.4 By Application
5.3.5 By End User
5.3.6 By Region
6. North America Next Generation Sequencing Kits Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
6.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
6.2.3. By Usage Area (Clinical, Research)
6.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
6.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Next Generation Sequencing Kits Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Workflow
6.3.1.2.2. By Sequencing Type
6.3.1.2.3. By Usage Area
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Next Generation Sequencing Kits Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Workflow
6.3.2.2.2. By Sequencing Type
6.3.2.2.3. By Usage Area
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Next Generation Sequencing Kits Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Workflow
6.3.3.2.2. By Sequencing Type
6.3.3.2.3. By Usage Area
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. Europe Next Generation Sequencing Kits Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
7.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
7.2.3. By Usage Area (Clinical, Research)
7.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
7.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. France Next Generation Sequencing Kits Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Workflow
7.3.1.2.2. By Sequencing Type
7.3.1.2.3. By Usage Area
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. Germany Next Generation Sequencing Kits Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Workflow
7.3.2.2.2. By Sequencing Type
7.3.2.2.3. By Usage Area
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. United Kingdom Next Generation Sequencing Kits Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Workflow
7.3.3.2.2. By Sequencing Type
7.3.3.2.3. By Usage Area
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. Italy Next Generation Sequencing Kits Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Workflow
7.3.4.2.2. By Sequencing Type
7.3.4.2.3. By Usage Area
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Next Generation Sequencing Kits Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Workflow
7.3.5.2.2. By Sequencing Type
7.3.5.2.3. By Usage Area
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. Asia-Pacific Next Generation Sequencing Kits Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
8.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
8.2.3. By Usage Area (Clinical, Research)
8.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
8.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Next Generation Sequencing Kits Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Workflow
8.3.1.2.2. By Sequencing Type
8.3.1.2.3. By Usage Area
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Next Generation Sequencing Kits Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Workflow
8.3.2.2.2. By Sequencing Type
8.3.2.2.3. By Usage Area
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Next Generation Sequencing Kits Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Workflow
8.3.3.2.2. By Sequencing Type
8.3.3.2.3. By Usage Area
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Next Generation Sequencing Kits Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Workflow
8.3.4.2.2. By Sequencing Type
8.3.4.2.3. By Usage Area
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Next Generation Sequencing Kits Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Workflow
8.3.5.2.2. By Sequencing Type
8.3.5.2.3. By Usage Area
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. South America Next Generation Sequencing Kits Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
9.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
9.2.3. By Usage Area (Clinical, Research)
9.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
9.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Next Generation Sequencing Kits Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Workflow
9.3.1.2.2. By Sequencing Type
9.3.1.2.3. By Usage Area
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. Argentina Next Generation Sequencing Kits Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Workflow
9.3.2.2.2. By Sequencing Type
9.3.2.2.3. By Usage Area
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Colombia Next Generation Sequencing Kits Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Workflow
9.3.3.2.2. By Sequencing Type
9.3.3.2.3. By Usage Area
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. Middle East and Africa Next Generation Sequencing Kits Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
10.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
10.2.3. By Usage Area (Clinical, Research)
10.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
10.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Next Generation Sequencing Kits Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Workflow
10.3.1.2.2. By Sequencing Type
10.3.1.2.3. By Usage Area
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Next Generation Sequencing Kits Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Workflow
10.3.2.2.2. By Sequencing Type
10.3.2.2.3. By Usage Area
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. UAE Next Generation Sequencing Kits Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Workflow
10.3.3.2.2. By Sequencing Type
10.3.3.2.3. By Usage Area
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.1.1 Growing advancement in NGS
11.1.2 Growing Demand for Early Detection of Chronic Diseases
11.2. Challenges
11.2.1 Lack of skilled professionals and infrastructure
11.2.2 Stringent Regulations
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Next Generation Sequencing Kits Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.5.1. Agilent Technologies, Inc.
15.5.2. Bio-Rad Laboratories, Inc.
15.5.3. BGI Group.
15.5.4. Creative Biogene
15.5.5. Danaher.
15.5.6. F. Hoffmann-La Roche Ltd.
15.5.7. Hologic, Inc.
15.5.8. Illumina, Inc.
15.5.9. Oxford Nanopore Technologies plc.
15.5.10. Pacific Biosciences of California, Inc.
15.5.11. PerkinElmer Inc.
16. Strategic Recommendations